Find Research outputs

Search results

• Article

  AP301, a synthetic peptide mimicking the lectin-like domain of TNF, enhances amiloride-sensitive Na⁺ current in primary dog, pig and rat alveolar type II cells

  Tzotzos, S., Fischer, B., Fischer, H., Pietschmann, H., Lucas, R., Dupré, G., Lemmens-Gruber, R., Hazemi, P., Prymaka, V. & Shabbir, W., Jun 2013, In: Pulmonary Pharmacology and Therapeutics. 26, 3, p. 356-363 8 p.

  Research output: Contribution to journal › Article › peer-review
  21 Scopus citations

• A PAGE screening approach for identifying CRISPR-Cas9-induced mutations in zebrafish

  VanLeuven, A. J., Park, S., Menke, D. B. & Lauderdale, J. D., Jun 2018, In: BioTechniques. 64, 6, p. 275-278 4 p.

  Research output: Contribution to journal › Article › peer-review
  9 Scopus citations

• A Pan-Cancer Analysis of Enhancer Expression in Nearly 9000 Patient Samples

  The Cancer Genome Atlas Research Network, Apr 5 2018, In: Cell. 173, 2, p. 386-399.e12

  Research output: Contribution to journal › Article › peer-review

  Open Access
  154 Scopus citations

• A pan-cancer perspective of matrix metalloproteases (MMP) gene expression profile and their diagnostic/prognostic potential

  Gobin, E., Bagwell, K., Wagner, J., Mysona, D., Sandirasegarane, S., Smith, N., Bai, S., Sharma, A., Schleifer, R. & She, J. X., Jun 14 2019, In: BMC Cancer. 19, 1, 581.

  Research output: Contribution to journal › Article › peer-review

  Open Access
  119 Scopus citations

• A pan-cancer review of ALK mutations: Implications for carcinogenesis and therapy

  Yau, N. K. M., Fong, A. Y., Leung, H. F., Verhoeft, K. R., Lim, Q. Y., Lam, W. Y., Wong, I. C. K. & Lui, V. W. Y., Jun 1 2015, In: Current cancer drug targets. 15, 4, p. 327-336 10 p.

  Research output: Contribution to journal › Article › peer-review
  19 Scopus citations

• A parallel bucket sort

  Chlebus, B. S., Feb 29 1988, In: Information Processing Letters. 27, 2, p. 57-61 5 p.

  Research output: Contribution to journal › Article › peer-review
  11 Scopus citations

• A Paratesticular Serous Borderline Tumor in a Pediatric Patient with Proteus Syndrome

  Klaassen, Z., Fox, P. J., McLees, L., Zheng, M., Sharma, S., Donohoe, J. M. & Neal, D. E., Dec 1 2015, In: Urology. 86, 6, p. 1218-1221 4 p.

  Research output: Contribution to journal › Article › peer-review
  2 Scopus citations

• A Partition Theorem for a Randomly Selected Large Population

  Rao, A. S. R. S., Mar 2022, In: Acta Biotheoretica. 70, 1, 6.

  Research output: Contribution to journal › Article › peer-review

• A patient-centered asthma management communication intervention for rural latino children: Protocol for a waiting-list randomized controlled trial

  Dawson, R. M., Heiney, S. P., Messias, D. A. H. & Ownby, D., Dec 2020, In: JMIR Research Protocols. 9, 12, e18977.

  Research output: Contribution to journal › Article › peer-review

  Open Access

• A Patient-Derived, Pan-Cancer EMT Signature Identifies Global Molecular Alterations and Immune Target Enrichment Following Epithelial-to-Mesenchymal Transition

  Mak, M. P., Tong, P., Diao, L., Cardnell, R. J., Gibbons, D. L., William, W. N., Skoulidis, F., Parra, E. R., Rodriguez-Canales, J., Wistuba, I. I., Heymach, J. V., Weinstein, J. N., Coombes, K. R., Wang, J. & Byers, L. A., Feb 1 2016, In: Clinical Cancer Research. 22, 3, p. 609-620 12 p.

  Research output: Contribution to journal › Article › peer-review
  294 Scopus citations

• A patient with concurrent primary hyperaldosteronism and adrenal insufficiency

  Puentes, F., Jackson, T. W. & Isales, C. M., Dec 2004, In: American Journal of the Medical Sciences. 328, 6, p. 344-347 4 p.

  Research output: Contribution to journal › Article › peer-review

• A patient with moderate post-operative hypertension presenting with posterior reversible encephalopathy syndrome: a case report

  Riaz, N., Behnia, M. M., Catalano, P. W. & Davis, J., 2013, In: Tanaffos. 12, 3, p. 58-61 4 p.

  Research output: Contribution to journal › Article › peer-review

  1 Scopus citations

• APBP-1, a DNA/RNA-binding protein, interacts with the chick aggrecan regulatory region

  Pirok, E. W., Domowicz, M. S., Henry, J., Wang, Y., Santore, M., Mueller, M. M. & Schwartz, N. B., Oct 21 2005, In: Journal of Biological Chemistry. 280, 42, p. 35606-35616 11 p.

  Research output: Contribution to journal › Article › peer-review
  4 Scopus citations

• APC dysfunction is correlated with defective suppression of T cell proliferation in human type 1 diabetes

  Jin, Y., Chen, X., Podolsky, R., Hopkins, D., Makala, L. H. C., Muir, A. & She, J. X., Mar 2009, In: Clinical Immunology. 130, 3, p. 272-279 8 p.

  Research output: Contribution to journal › Article › peer-review
  22 Scopus citations

• Apelin/APJ signaling is a critical regulator of statin effects in vascular endothelial cells-brief report

  McLean, D. L., Kim, J., Kang, Y., Shi, H., Atkins, G. B., Jain, M. K. & Chun, H. J., Nov 2012, In: Arteriosclerosis, thrombosis, and vascular biology. 32, 11, p. 2640-2643 4 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access
  21 Scopus citations

• A penalized regression approach for DNA copy number study using the sequencing data

  Lee, J. & Chen, J., 2019, In: Statistical Applications in Genetics and Molecular Biology. 18, 4, 20180001.

  Research output: Contribution to journal › Article › peer-review
  3 Scopus citations

• A peptide blocking the ADORA1-neurabin interaction is anticonvulsant and inhibits epilepsy in an Alzheimer’s model

  Saggu, S., Chen, Y., Chen, L., Pizarro, D., Pati, S., Law, W. J., McMahon, L., Jiao, K. & Wang, Q., Jun 8 2022, In: JCI Insight. 7, 11, e155002.

  Research output: Contribution to journal › Article › peer-review

  Open Access

• A percolation model of diagenesis

  Manna, S. S., Datta, T., Karmakar, R. & Tarafdar, S., 2002, In: International Journal of Modern Physics C. 13, 3, p. 319-331 13 p.

  Research output: Contribution to journal › Article › peer-review
  4 Scopus citations

• A periodic pattern generator for dental diversity

  Fraser, G. J., Bloomquist, R. F. & Streelman, J. T., Jul 14 2008, In: BMC Biology. 6, 32.

  Research output: Contribution to journal › Article › peer-review

  Open Access
  84 Scopus citations

• A personalized medicine approach to ovulation induction/ovarian stimulation: development of a predictive model and online calculator from level-I evidence

  for the Eunice Kennedy Schriver National Institute of Child Health and Human Development Reproductive Medicine Network, Feb 2022, In: Fertility and sterility. 117, 2, p. 408-418 11 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access
  3 Scopus citations

• A personalized paradigm in the treatment of platinum-resistant ovarian cancer: A cost utility analysis of genomic-based versus cytotoxic therapy

  Wallbillich, J. J., Forde, B., Havrilesky, LJ. & Cohn, DE., Jul 2016, In: Gynecologic Oncology. 142, 1, p. 144-149 6 p., 27106017.

  Research output: Contribution to journal › Article › peer-review

  11 Scopus citations

• Aphaenogaster ichnusa santschi, 1925, bona species, and redescription of aphaenogaster subterranea (latreille, 1798) (hymenoptera, formicidae)

  Galkowski, C., Aubert, C. & Blatrix, R., 2019, In: Sociobiology. 66, 3, p. 420-425 6 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access
  9 Scopus citations

• A pharmacodynamic study of the FLT3 inhibitor KW-2449 yields insight into the basis for clinical response

  Pratz, K. W., Cortes, J., Roboz, G. J., Rao, N., Arowojolu, O., Stine, A., Shiotsu, Y., Shudo, A., Akinaga, S., Small, D., Karp, J. E. & Levis, M., 2009, In: Unknown Journal. 113, 17, p. 3938-3946 9 p.

  Research output: Contribution to journal › Article › peer-review
  149 Scopus citations

• A pharmacogenetic versus a clinical algorithm for warfarin dosing

  Kimmel, S. E., French, B., Kasner, S. E., Johnson, J. A., Anderson, J. L., Gage, B. F., Rosenberg, Y. D., Eby, C. S., Madigan, R. A., McBane, R. B., Abdel-Rahman, S. Z., Stevens, S. M., Yale, S., Mohler, E. R., Fang, M. C., Shah, V., Horenstein, R. B., Limdi, N. A., Muldowney, J. A. S., Gujral, J. S., & 11 othersDelafontaine, P., Desnick, R. J., Ortel, T. L., Billett, H. H., Pendleton, R. C., Geller, N. L., Halperin, J. L., Goldhaber, S. Z., Caldwell, M. D., Califf, R. M. & Ellenberg, J. H., 2013, In: New England Journal of Medicine. 369, 24, p. 2283-2293 11 p.

  Research output: Contribution to journal › Article › peer-review
  615 Scopus citations

• A pharmacokinetic-pharmacodynamic model for a muscle relaxant: Atracurium

  Nigrovic, V., Gaspari, J. & Banoub, M., Jan 1 1996, In: European Journal of Clinical Pharmacology. 49, 4, p. 325-332 8 p.

  Research output: Contribution to journal › Article › peer-review
  2 Scopus citations

• A pharmacotherapy review of the novel, oral antithrombotics

  Walters, K. J., Meador, A., Galdo, J. A. & Ciarrocca, K., Mar 1 2017, In: Special Care in Dentistry. 37, 2, p. 62-70 9 p.

  Research output: Contribution to journal › Article › peer-review
  1 Scopus citations

• A phase 1/2 trial of HQK-1001, an oral fetal globin inducer, in sickle cell disease

  Kutlar, A., Ataga, K., Reid, M., Vichinsky, E. P., Neumayr, L., Blair-Britt, L., Labotka, R., Glass, J., Keefer, J. R., Wargin, W. A., Berenson, R. & Perrine, S. P., Nov 2012, In: American Journal of Hematology. 87, 11, p. 1017-1021 5 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access
  25 Scopus citations

• A phase 1-2 study of a farnesyltransferase inhibitor, tipifarnib, combined with idarubicin and cytarabine for patients with newly diagnosed acute myeloid leukemia and high-risk myelodysplastic syndrome

  Jabbour, E., Kantarjian, H., Ravandi, F., Garcia-Manero, G., Estrov, Z., Verstovsek, S., O'Brien, S., Faderl, S., Thomas, D. A., Wright, J. J. & Cortes, J., Mar 15 2011, In: Cancer. 117, 6, p. 1236-1244 9 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access
  32 Scopus citations

• A phase 1b/2b multicenter study of oral panobinostat plus azacitidine in adults with MDS, CMML or AML with ≤30% blasts

  Garcia-Manero, G., Sekeres, M. A., Egyed, M., Breccia, M., Graux, C., Cavenagh, J. D., Salman, H., Illes, A., Fenaux, P., Deangelo, D. J., Stauder, R., Yee, K., Zhu, N., Lee, J. H., Valcarcel, D., Macwhannell, A., Borbenyi, Z., Gazi, L., Acharyya, S., Ide, S., & 2 othersMarker, M. & Ottmann, O. G., 2017, In: Leukemia. 31, 12, p. 2799-2806 8 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access
  47 Scopus citations

• A phase 1 open-label, sequential dose-escalation study investigating the safety, tolerability, and pharmacokinetics of intravenous TLC388 administered to patients with advanced solid tumors

  Ghamande, S., Lin, C. C., Cho, D. C., Shapiro, G. I., Kwak, E. L., Silverman, M. H., Tseng, Y., Kuo, M. W., Mach, W. B., Hsu, S. C., Coleman, T., Yang, J. C. H., Cheng, A. L., Ghalib, M. H., Chuadhary, I. & Goel, S., Jun 2014, In: Investigational New Drugs. 32, 3, p. 445-451 7 p.

  Research output: Contribution to journal › Article › peer-review
  20 Scopus citations

• A phase 1 randomized, double-blind, placebo-controlled, crossover trial of DAS181 (Fludase®) in adult subjects with well-controlled asthma

  Colombo, R. E., Fiorentino, C., Dodd, L. E., Hunsberger, S., Haney, C., Barrett, K., Nabha, L., Davey, R. T. & Olivier, K. N., Feb 1 2016, In: BMC Infectious Diseases. 16, 1, 54.

  Research output: Contribution to journal › Article › peer-review

  Open Access
  16 Scopus citations

• A phase 1 trial of vadastuximab talirine as monotherapy in patients with CD33-positive acute myeloid leukemia

  Stein, E. M., Walter, R. B., Erba, H. P., Fathi, A. T., Advani, A. S., Lancet, J. E., Ravandi, F., Kovacsovics, T., DeAngelo, D. J., Bixby, D., Faderl, S., Jillella, A. P., Ho, P. A., O'Meara, M. M., Zhao, B., Biddle-Snead, C. & Stein, A. S., Jan 25 2018, In: Blood. 131, 4, p. 387-396 10 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access
  107 Scopus citations

• A phase 1 trial of vadastuximab talirine combined with hypomethylating agents in patients with CD33-positive AML

  Fathi, A. T., Erba, H. P., Lancet, J. E., Stein, E. M., Ravandi, F., Faderl, S., Walter, R. B., Advani, A. S., DeAngelo, D. J., Kovacsovics, T. J., Jillella, A., Bixby, D., Levy, M. Y., O’Meara, M. M., Ho, P. A., Voellinger, J. & Stein, A. S., Sep 13 2018, In: Blood. 132, 11, p. 1125-1133 9 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access
  44 Scopus citations

• A phase 2, double-blinded, placebo-controlled trial of toll-like receptor 7/8/9 antagonist, IMO-8400, in dermatomyositis

  Kim, Y. J., Schiopu, E., Dankó, K., Mozaffar, T., Chunduru, S., Lees, K., Goyal, N. A., Sarazin, J., Fiorentino, D. F. & Sarin, K. Y., Apr 2021, In: Journal of the American Academy of Dermatology. 84, 4, p. 1160-1162 3 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access
  3 Scopus citations

• A phase 2, open-label study of the safety and efficacy of intravenous anidulafungin as a treatment for azole-refractory mucosal candidiasis

  Vazquez, J. A., Schranz, J. A., Clark, K., Goldstein, B. P., Reboli, A. & Fichtenbaum, C., Jul 1 2008, In: Journal of Acquired Immune Deficiency Syndromes. 48, 3, p. 304-309 6 p.

  Research output: Contribution to journal › Article › peer-review
  37 Scopus citations

• A Phase 2, Randomized, Control Trial of Group B Streptococcus (GBS) Type III Capsular Polysaccharide-tetanus Toxoid (GBS III-TT) Vaccine to Prevent Vaginal Colonization with GBS III

  Hillier, S. L., Ferrieri, P., Edwards, M. S., Ewell, M., Ferris, D., Fine, P., Carey, V., Meyn, L., Hoagland, D., Kasper, D. L., Paoletti, L. C., Hill, H. & Baker, C. J., Jun 2019, In: Clinical Infectious Diseases. 68, 12, p. 2079-2086 8 p., ciy838.

  Research output: Contribution to journal › Article › peer-review
  23 Scopus citations

• A phase 2, randomized, double-blind, placebo- controlled study of chemo-immunotherapy combination using motolimod with pegylated liposomal doxorubicin in recurrent or persistent ovarian cancer: a Gynecologic Oncology Group partners study

  Monk, B. J., Brady, M. F., Aghajanian, C., Lankes, H. A., Rizack, T., Leach, J., Fowler, J. M., Higgins, R., Hanjani, P., Morgan, M., Edwards, R., Bradley, W., Kolevska, T., Foukas, P., Swisher, E. M., Anderson, K. S., Gottardo, R., Bryan, J. K., Newkirk, M., Manjarrez, K. L., & 3 othersMannel, R. S., Hershberg, R. M. & Coukos, G., May 1 2017, In: Annals of oncology : official journal of the European Society for Medical Oncology. 28, 5, p. 996-1004 9 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access
  47 Scopus citations

• A phase 2, randomized, double-blind, placebo-controlled trial of clinical activity and safety of subcutaneous Å6 in women with asymptomatic CA125 progression after first-line chemotherapy of epithelial ovarian cancer

  Ghamande, S. A., Silverman, M. H., Huh, W., Behbakht, K., Ball, G., Cuasay, L., Würtz, S. O., Brunner, N. & Gold, M. A., Oct 2008, In: Gynecologic Oncology. 111, 1, p. 89-94 6 p.

  Research output: Contribution to journal › Article › peer-review
  39 Scopus citations

• A Phase 2a dose-escalation study of the safety, tolerability, pharmacokinetics and haemodynamic effects of BMS-986231 in hospitalized patients with heart failure with reduced ejection fraction

  Tita, C., Gilbert, E. M., Van Bakel, A. B., Grzybowski, J., Haas, G. J., Jarrah, M., Dunlap, S. H., Gottlieb, S. S., Klapholz, M., Patel, P. C., Pfister, R., Seidler, T., Shah, K. B., Zieliński, T., Venuti, R. P., Cowart, D., Foo, S. Y., Vishnevsky, A. & Mitrovic, V., Oct 2017, In: European Journal of Heart Failure. 19, 10, p. 1321-1332 12 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access
  41 Scopus citations

• A phase 2 study of MK-0457 in patients with BCR-ABL T315I mutant chronic myelogenous leukemia and philadelphia chromosome-positive acute lymphoblastic leukemia

  Seymour, J. F., Kim, D. W., Rubin, E., Haregewoin, A., Clark, J., Watson, P., Hughes, T., Dufva, I., Jimenez, J. L., Mahon, F. X., Rousselot, P., Cortes, J., Martinelli, G., Papayannidis, C., Nagler, A. & Giles, F. J., Aug 2014, In: Blood Cancer Journal. 4, 8, e238.

  Research output: Contribution to journal › Article › peer-review

  Open Access
  54 Scopus citations

• A phase 2 study of oxaliplatin combined with continuous infusion topotecan for patients with previously treated ovarian cancer

  Stein, S. M., Tiersten, A., Hochster, H. S., Blank, S. V., Pothuri, B., Curtin, J., Shapira, I., Levinson, B., Ivy, P., Joseph, B., Guddati, A. K. & Muggia, F., 2013, In: International Journal of Gynecological Cancer. 23, 9, p. 1577-1582 6 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access
  8 Scopus citations

• A phase 2 study of ruxolitinib in combination with azacitidine in patients with myelofibrosis

  Masarova, L., Verstovsek, S., Hidalgo-Lopez, J. E., Pemmaraju, N., Bose, P., Estrov, Z., Jabbour, E. J., Ravandi-Kashani, F., Takahashi, K., Cortes, J. E., Ning, J., Ohanian, M., Alvarado, Y., Zhou, L., Pierce, S., Gergis, R., Patel, K. P., Luthra, R., Kadia, T. M., DiNardo, C. D., & 6 othersBorthakur, G., Bhalla, K., Garcia-Manero, G., Bueso-Ramos, C. E., Kantarjian, H. M. & Daver, N., Oct 18 2018, In: Blood. 132, 16, p. 1664-1674 11 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access
  49 Scopus citations

• A phase 2 trial of ponatinib in Philadelphia chromosome-positive leukemias

  Cortes, J. E., Kim, D. W., Pinilla-Ibarz, J., Le Coutre, P., Paquette, R., Chuah, C., Nicolini, F. E., Apperley, J. F., Khoury, H. J., Talpaz, M., DiPersio, J., DeAngelo, D. J., Abruzzese, E., Rea, D., Baccarani, M., Müller, M. C., Gambacorti-Passerini, C., Wong, S., Lustgarten, S., Rivera, V. M., & 10 othersClackson, T., Turner, C. D., Haluska, F. G., Guilhot, F., Deininger, M. W., Hochhaus, A., Hughes, T., Goldman, J. M., Shah, N. P. & Kantarjian, H., 2013, In: New England Journal of Medicine. 369, 19, p. 1783-1796 14 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access
  823 Scopus citations

• A phase 3, open-label, randomized study of asciminib, a STAMP inhibitor, vs bosutinib in CML after 2 or more prior TKIs

  Réa, D., Mauro, M. J., Boquimpani, C., Minami, Y., Lomaia, E., Voloshin, S., Turkina, A., Kim, D. W., Apperley, J. F., Abdo, A., Fogliatto, L. M., Kim, D. D. H., le Coutre, P., Saussele, S., Annunziata, M., Hughes, T. P., Chaudhri, N., Sasaki, K., Chee, L., García-Gutiérrez, V., & 6 othersCortes, J. E., Aimone, P., Allepuz, A., Quenet, S., Bédoucha, V. & Hochhaus, A., Nov 25 2021, In: Blood. 138, 21, p. 2031-2041 11 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access
  86 Scopus citations

• A phase I, open-label, multi-center study of the JAK2 inhibitor AZD1480 in patients with myelofibrosis

  Verstovsek, S., Hoffman, R., Mascarenhas, J., Soria, J. C., Bahleda, R., McCoon, P., Tang, W., Cortes, J., Kantarjian, H. & Ribrag, V., Feb 1 2015, In: Leukemia Research. 39, 2, p. 157-163 7 p.

  Research output: Contribution to journal › Article › peer-review
  27 Scopus citations

• A phase I/II randomized trial of clofarabine or fludarabine added to idarubicin and cytarabine for adults with relapsed or refractory acute myeloid leukemia

  Short, N. J., Kantarjian, H., Ravandi, F., Huang, X., Xiao, L., Garcia-Manero, G., Plunkett, W., Gandhi, V., Sasaki, K., Pemmaraju, N., Daver, N. G., Borthakur, G., Jain, N., Konopleva, M., Estrov, Z., Kadia, T. M., Wierda, W. G., DiNardo, C. D., Brandt, M., O’Brien, S. M., & 2 othersCortes, J. E. & Jabbour, E., Jul 19 2018, In: Leukemia and Lymphoma. 59, 4, p. 813-820 8 p.

  Research output: Contribution to journal › Article › peer-review
  14 Scopus citations

• A phase I/II study of the combination of quizartinib with azacitidine or low-dose cytarabine for the treatment of patients with acute myeloid leukemia or myelodysplastic syndrome

  Swaminathan, M., Kantarjian, H. M., Levis, M., Guerra, V., Borthakur, G., Alvarado, Y., DiNardo, C. D., Kadia, T., Garcia-Manero, G., Ohanian, M., Daver, N., Konopleva, M., Pemmaraju, N., Ferrajol, A., Andreeff, M., Jain, N., Estrov, Z., Jabbour, E. J., Wierda, W. G., Pierce, S., & 4 othersPinsoy, M. R., Xiao, L., Ravandi, F. & Cortes, J. E., Aug 2021, In: Haematologica. 106, 8, p. 2121-2130 10 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access
  26 Scopus citations

• A phase I/II study of the Janus kinase (JAK)1 and 2 inhibitor ruxolitinib in patients with relapsed or refractory acute myeloid leukemia

  Pemmaraju, N., Kantarjian, H., Kadia, T., Cortes, J., Borthakur, G., Newberry, K., Garcia-Manero, G., Ravandi, F., Jabbour, E., Dellasala, S., Pierce, S. & Verstovsek, S., Mar 1 2015, In: Clinical Lymphoma, Myeloma and Leukemia. 15, 3, p. 171-176 6 p.

  Research output: Contribution to journal › Article › peer-review
  61 Scopus citations

• A phase I/II study of the mTOR inhibitor everolimus in combination with hyperCVAD chemotherapy in patients with relapsed/refractory acute lymphoblastic leukemia

  Daver, N., Boumber, Y., Kantarjian, H., Ravandi, F., Cortes, J., Rytting, M. E., Kawedia, J. D., Basnett, J., Culotta, K. S., Zeng, Z., Lu, H., Richie, M. A., Garris, R., Xiao, L., Liu, W., Baggerly, K. A., Jabbour, E., O'Brien, S., Burger, J., Bendall, L. J., & 2 othersThomas, D. & Konopleva, M., Jun 15 2015, In: Clinical Cancer Research. 21, 12, p. 2704-2714 11 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access
  42 Scopus citations

• A phase i and pharmacodynamic study of AT9283, a small-molecule inhibitor of aurora kinases in patients with relapsed/refractory leukemia or myelofibrosis

  Foran, J., Ravandi, F., Wierda, W., Garcia-Manero, G., Verstovsek, S., Kadia, T., Burger, J., Yule, M., Langford, G., Lyons, J., Ayrton, J., Lock, V., Borthakur, G., Cortes, J. & Kantarjian, H., Jun 2014, In: Clinical Lymphoma, Myeloma and Leukemia. 14, 3, p. 223-230 8 p.

  Research output: Contribution to journal › Article › peer-review
  32 Scopus citations